UBC Medical Indonesia Tbk. vs Lippo Karawaci Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Lippo Karawaci Tbk. trades at Rp63 (market cap 4.25T, 148.64M 24h volume). The key difference: Lippo Karawaci Tbk. is far larger — about 7.4× UBC Medical Indonesia Tbk.'s market cap, and Lippo Karawaci Tbk. is more actively traded (148.64M versus 3.48M). Which is the better fit depends on your goals.
| LABS | LPKR | |
|---|---|---|
Market Cap | 576.7B | 4.25T |
Volume | 3.48M | 148.64M |
Lot | 34.82K | 1.49M |
Turnover | 522.79M | 9.21B |
Average Price | 150.13 | 61.95 |
Value | 522.79M | 9.21B |
Indicative Equilibrium Price | 148 | 63 |
Indicative Equilibrium Volume | 350 | 18.08K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.
Read more on LPKR →